Exome Asset Management LLC
- SEC CIK
- 0002011932
- 最新申報
- 2026/8/14
2026 年第 2 季持倉
持倉截至 2026/6/30，2026/8/14 申報。只含多頭部位，變化是跟 2026 年第 1 季比股數。
- 持股檔數
- 52
- 較 2026 年第 1 季 +7
- 總值
- $1.62 億
- 較 2026 年第 1 季 −$784.4 萬 (−4.6%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| GHGuardant Health, Inc. | COM | 67,500 | $1,013 萬 | 6.2% | −15,236−18.4% | 減碼 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 27,205 | $910.8 萬 | 5.6% | −18,264−40.2% | 減碼 | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 164,915 | $906.0 萬 | 5.6% | +164,915 | 新進 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 210,523 | $814.7 萬 | 5.0% | −68,010−24.4% | 減碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 88,177 | $699.2 萬 | 4.3% | −21,887−19.9% | 減碼 | 歷史 |
| LLYEli Lilly & Co | Stock | 5,492 | $658.7 萬 | 4.1% | −1,520−21.7% | 減碼 | 歷史 |
| ABVXAbivax S.A. | SPONSORED ADS | 46,878 | $624.7 萬 | 3.9% | +46,878 | 新進 | 歷史 |
| ALMSAlumis Inc. | COM | 204,418 | $575.2 萬 | 3.5% | −74,758−26.8% | 減碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 60,056 | $511.6 萬 | 3.2% | −43,662−42.1% | 減碼 | 歷史 |
| ELVNEnliven Therapeutics, Inc. | COM | 100,203 | $508.5 萬 | 3.1% | −119,888−54.5% | 減碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 97,276 | $417.4 萬 | 2.6% | −17,715−15.4% | 減碼 | 歷史 |
| UNHUnitedHealth Group Inc | Stock | 9,612 | $399.5 萬 | 2.5% | −3,250−25.3% | 減碼 | 歷史 |
| TXG10x Genomics, Inc. | CL A COM | 102,629 | $393.5 萬 | 2.4% | −51,565−33.4% | 減碼 | 歷史 |
| NTRANatera, Inc. | COM | 13,800 | $374.6 萬 | 2.3% | −4,850−26.0% | 減碼 | 歷史 |
| QUREuniQure N.V. | SHS | 81,056 | $373.3 萬 | 2.3% | +81,056 | 新進 | 歷史 |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 32,209 | $357.6 萬 | 2.2% | −8,372−20.6% | 減碼 | 歷史 |
| MAZEMaze Therapeutics, Inc. | COM | 114,692 | $342.2 萬 | 2.1% | +26,182+29.6% | 加碼 | 歷史 |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 137,115 | $331.8 萬 | 2.0% | −42,369−23.6% | 減碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 166,493 | $324.2 萬 | 2.0% | −48,883−22.7% | 減碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 61,336 | $321.4 萬 | 2.0% | −22,767−27.1% | 減碼 | 歷史 |
| LQDALiquidia Corp | COM NEW | 39,224 | $312.7 萬 | 1.9% | −6,572−14.4% | 減碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 5,410 | $293.1 萬 | 1.8% | −1,643−23.3% | 減碼 | 歷史 |
| GKOSGLAUKOS Corp | COM | 19,862 | $277.6 萬 | 1.7% | −1,012−4.8% | 減碼 | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 32,214 | $262.6 萬 | 1.6% | −13,507−29.5% | 減碼 | 歷史 |
| AGIOAgios Pharmaceuticals, Inc. | COM | 70,500 | $261.6 萬 | 1.6% | −54,560−43.6% | 減碼 | 歷史 |
| CBIOCrescent Biopharma, Inc. | COM | 127,769 | $230.0 萬 | 1.4% | −25,422−16.6% | 減碼 | 歷史 |
| AZNAstraZeneca PLC | ADR | 12,045 | $225.4 萬 | 1.4% | +12,045 | 新進 | 歷史 |
| BSXBoston Scientific Corp | Stock | 48,347 | $206.3 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| ADAGAdagene Inc. | ADS | 488,293 | $205.1 萬 | 1.3% | −248,552−33.7% | 減碼 | 歷史 |
| PENPenumbra Inc | COM | 6,300 | $198.9 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| ISRGIntuitive Surgical Inc | COM NEW | 4,908 | $195.2 萬 | 1.2% | −1,450−22.8% | 減碼 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 47,861 | $186.7 萬 | 1.2% | +47,861 | 新進 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 181,588 | $178.3 萬 | 1.1% | +181,588 | 新進 | 歷史 |
| EQEquillium, Inc. | COM | 552,956 | $176.9 萬 | 1.1% | +552,956 | 新進 | 歷史 |
| ASNDAscendis Pharma A/S | ORD SHS | 6,573 | $175.3 萬 | 1.1% | +6,573 | 新進 | 歷史 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 184,914 | $173.4 萬 | 1.1% | −49,222−21.0% | 減碼 | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 460,067 | $172.5 萬 | 1.1% | −61,401−11.8% | 減碼 | 歷史 |
| VSTMVerastem, Inc. | COM NEW | 429,041 | $163.9 萬 | 1.0% | −207,659−32.6% | 減碼 | 歷史 |
| NKTRNektar Therapeutics | COM NEW | 22,417 | $156.5 萬 | 1.0% | +22,417 | 新進 | 歷史 |
| CLPTClearPoint Neuro, Inc. | COM | 83,636 | $149.2 萬 | 0.9% | +83,636 | 新進 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 13,873 | $147.9 萬 | 0.9% | −12,778−47.9% | 減碼 | 歷史 |
| CAICaris Life Sciences, Inc. | COM | 78,180 | $139.3 萬 | 0.9% | +78,180 | 新進 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 18,359 | $136.7 萬 | 0.8% | −49,133−72.8% | 減碼 | 歷史 |
| ZBIOZenas BioPharma, Inc. | COM | 52,443 | $133.1 萬 | 0.8% | −28,287−35.0% | 減碼 | 歷史 |
| NBPNovaBridge Biosciences | SPONSORED ADS | 576,960 | $112.5 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 13,100 | $112.4 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 47,531 | $88.9 萬 | 0.5% | −230,771−82.9% | 減碼 | 歷史 |
| GERNGeron Corp | COM | 624,046 | $79.9 萬 | 0.5% | +624,046 | 新進 | 歷史 |
| DRUGBright Minds Biosciences Inc. | COM NEW | 10,110 | $71.0 萬 | 0.4% | +10,110 | 新進 | 歷史 |
| CMPXCompass Therapeutics, Inc. | COM | 276,165 | $60.5 萬 | 0.4% | +276,165 | 新進 | 歷史 |
| REPLReplimune Group, Inc. | COM | 40,361 | $44.7 萬 | 0.3% | +40,361 | 新進 | 歷史 |
| ABUSArbutus Biopharma Corp | COM | 50,166 | $24.1 萬 | 0.1% | −25,318−33.5% | 減碼 | 歷史 |
2026 年第 1 季之後清倉（8 檔）
2026 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2026 年第 1 季股數 | 2026 年第 1 季市值 | 2026 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ELVElevance Health, Inc. | Stock | 14,677 | $429.7 萬 | 2.5% | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 85,517 | $344.0 萬 | 2.0% | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 159,341 | $237.9 萬 | 1.4% | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 61,673 | $206.5 萬 | 1.2% | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 130,564 | $121.6 萬 | 0.7% | 歷史 |
| NXTCNextCure, Inc. | COM NEW | 115,500 | $121.5 萬 | 0.7% | 歷史 |
| PALIPalisade Bio, Inc. | COM | 600,000 | $105.0 萬 | 0.6% | 歷史 |
| LPCNLipocine Inc. | COM NEW | 60,861 | $48.6 萬 | 0.3% | 歷史 |